Anna Polak

456 total citations
26 papers, 239 citations indexed

About

Anna Polak is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Anna Polak has authored 26 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Immunology. Recurrent topics in Anna Polak's work include Cancer Mechanisms and Therapy (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Ubiquitin and proteasome pathways (4 papers). Anna Polak is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Ubiquitin and proteasome pathways (4 papers). Anna Polak collaborates with scholars based in Poland, United Kingdom and United States. Anna Polak's co-authors include Maciej Szydłowski, Przemysław Juszczyński, Emilia Białopiotrowicz, Patryk Górniak, Krzysztof Warzocha, Ewa Jabłońska, Monika Prochorec‐Sobieszek, Anna Szumera‐Ciećkiewicz, Sergiusz Markowicz and Ewa Lech‐Marańda and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Anna Polak

20 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Polak Poland 8 113 75 70 43 35 26 239
Deborah Morena Italy 8 222 2.0× 56 0.7× 75 1.1× 35 0.8× 92 2.6× 11 351
Teresa Laguna Spain 9 106 0.9× 40 0.5× 86 1.2× 51 1.2× 56 1.6× 11 254
Xuebing Jia China 12 195 1.7× 34 0.5× 58 0.8× 51 1.2× 121 3.5× 17 293
Vahid Reza Yassaee Iran 10 169 1.5× 26 0.3× 29 0.4× 29 0.7× 55 1.6× 42 301
Asuka Hira Japan 6 238 2.1× 28 0.4× 32 0.5× 19 0.4× 75 2.1× 9 293
Wencai Ma United States 11 271 2.4× 30 0.4× 98 1.4× 79 1.8× 43 1.2× 17 397
Juan Luiz Coelho‐Silva Brazil 10 155 1.4× 19 0.3× 43 0.6× 25 0.6× 52 1.5× 35 264
Julia W. Grimstead United Kingdom 12 256 2.3× 17 0.2× 58 0.8× 31 0.7× 26 0.7× 20 420
Elaine M. Oberlick United States 4 219 1.9× 60 0.8× 82 1.2× 35 0.8× 56 1.6× 5 302
Ewa Jabłońska Poland 8 136 1.2× 88 1.2× 78 1.1× 65 1.5× 47 1.3× 21 275

Countries citing papers authored by Anna Polak

Since Specialization
Citations

This map shows the geographic impact of Anna Polak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Polak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Polak more than expected).

Fields of papers citing papers by Anna Polak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Polak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Polak. The network helps show where Anna Polak may publish in the future.

Co-authorship network of co-authors of Anna Polak

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Polak. A scholar is included among the top collaborators of Anna Polak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Polak. Anna Polak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Górniak, Patryk, Ondřej Havránek, Anna Polak, & Przemysław Juszczyński. (2023). Role of Autoantigen Induced-B-Cell Receptor Internalization and Its Inhibition for the Biology and Survival of Diffuse Large B-Cell Lymphoma (DLBCL) Cells. Blood. 142(Supplement 1). 4141–4141. 1 indexed citations
2.
Białopiotrowicz, Emilia, Ewa Jabłońska, Magdalena Wojtas, et al.. (2023). SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas. Cell Death and Disease. 14(10). 667–667. 4 indexed citations
3.
Göller, Kristina, Jan Maciej Zaucha, Ewa Zarzycka, et al.. (2021). RVU120 (SEL120) CDK8/19 Inhibitor - a Drug Candidate for the Treatment of MDS Can Induce Erythroid Differentiation. Blood. 138(Supplement 1). 1518–1518.
4.
Górniak, Patryk, Iwona Ługowska, Piotr Rutkowski, et al.. (2020). BRAF inhibition curtails IFN‐gamma‐inducible PD‐L1 expression and upregulates the immunoregulatory protein galectin‐1 in melanoma cells. Molecular Oncology. 14(8). 1817–1832. 14 indexed citations
6.
Górniak, Patryk, et al.. (2018). BRAF V600E mutation in melanoma sustains IFN-gamma inducible PD-L1 expression by coactivating STAT1 and increasing protein translation. Annals of Oncology. 29. viii463–viii464. 1 indexed citations
7.
Szydłowski, Maciej, Monika Prochorec‐Sobieszek, Anna Szumera‐Ciećkiewicz, et al.. (2017). EXPRESSION OF PIM KINASES IN REED‐STERNBERG CELLS FOSTERS IMMUNE PRIVILEGE AND TUMOR CELL SURVIVAL IN HODGKIN LYMPHOMA. Hematological Oncology. 35(S2). 398–399. 3 indexed citations
8.
Kamińska, Joanna, Anna Polak, Krzysztof Flis, et al.. (2016). Phosphatidylinositol-3-phosphate regulates response of cells to proteotoxic stress. The International Journal of Biochemistry & Cell Biology. 79. 494–504. 22 indexed citations
9.
Polak, Anna, Maciej Szydłowski, Ewa Jabłońska, et al.. (2016). MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy. PLoS ONE. 11(5). e0155893–e0155893. 25 indexed citations
10.
Jabłońska, Ewa, Patryk Górniak, Maciej Szydłowski, et al.. (2016). MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells. Experimental Hematology. 46. 56–61.e1. 17 indexed citations
11.
Białopiotrowicz, Emilia, Patryk Górniak, Bartosz Puła, et al.. (2016). Microenvironment-Induced Expression of PIM Kinases Supports Chronic Lymphocytic Leukemia Cells Survival and Promotes CXCR4-mTOR Pathway Dependent Migration. Blood. 128(22). 3239–3239. 3 indexed citations
12.
Szydłowski, Maciej, Ewa Jabłońska, Emilia Białopiotrowicz, et al.. (2016). FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism. Oncogene. 35(46). 5989–6000. 38 indexed citations
13.
Szydłowski, Maciej, Ewa Jabłońska, Emilia Białopiotrowicz, et al.. (2016). FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas. Blood. 127(6). 739–748. 40 indexed citations
14.
Szydłowski, Maciej, Emilia Białopiotrowicz, Ewa Jabłońska, et al.. (2015). FOXO1-p300-Txn Circuit Regulates Oxidative Stress Responses in Diffuse Large B-Cell Lymphomas Characterized By Enhanced Oxidative Phosphorylation. Blood. 126(23). 466–466.
15.
Polak, Anna, et al.. (2014). 5 Catalase Inhibition Augments Reactive Oxygen Species Production in Isolated Ventricular Myocytes. Heart. 100(Suppl 1). A3.1–A3. 1 indexed citations
16.
17.
Polak, Anna, et al.. (2006). [Estimation of magnetic radiation effects on leucocytes].. PubMed. 20(117). 350–4.
18.
Szewczyk, Maria T., et al.. (2006). Elderly patients suffering with chronic ulceration II. Depression risk factors. 14(1). 19–25.
19.
Kaźmierczak, Piotr, et al.. (2004). Influence of preischemic short-term triiodothyronine administration on hemodynamic function and metabolism of reperfused isolated rat heart.. PubMed. 10(10). BR381–7. 3 indexed citations
20.
Stefaniak, Tadeusz, et al.. (2002). Transfer of maternal passive immunity to kids in goat herd.. PubMed. 5(4). 251–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026